Notice of Intent to Sole Source Award SN75H70926BAO_032
Summary
AI-generated · Mar 17, 2026A firm-fixed-price, sole-source contract for human blood and blood products to support patient care is planned with The American National Red Cross for a base period plus two option years. The arrangement is valued below the simplified acquisition threshold. The Red Cross is considered uniquely qualified to provide regulated blood components that meet clinical, safety, and regulatory standards, and to maintain a national supply network and distribution capability that ensures timely delivery of blood types and components (e.g., red blood cells, plasma, platelets). Its proximity and logistics enable rapid fulfillment of routine and urgent transfusion needs, which is critical to patient treatment.
This is not a solicitation or request for quotes. The action is being pursued under FAR 6.302-1, with the government determining that only one responsible source can satisfy the requirements. Responses should present clear and convincing evidence that competition would be advantageous and not cost- or time-prohibitive, and would not hinder mission objectives. Inquiries should be directed to the Purchasing Agent via email, including the specified subject line, with no telephone inquiries accepted.
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Indian Health Service, Blackfeet Service Unit, Browning, MT, hereby submits a Notice of Intent to award a sole source, firm-fixed price contract for Blood and Blood Product services to The American National Red Cross, UEI: G69LHXJ3ABL5 Period of Performance is for a Base plus Two (2) Option Year Period as follows: Base Period: 04/01/2026 03/31/2027 Option Year One (1): 04/01/2027 03/31/2028 Option Year Two (2): 04/01/2028 03/31/2029 The estimated total value is below the simplified acquisition threshold. The sole source contracting action is pursuing a waiver from placing an order on a competitive basis pursuant to FAR 6.302-1, only one responsible source and no other supply or service will satisfy agency requirements. The Government requires a reliable source for the provision of human blood and blood products necessary to support patient care activities. The American Red Cross is uniquely qualified to provide these products due to its established capability to supply regulated blood components that meet all applicable clinical, safety, and regulatory standards. Additionally, The American Red Cross maintains an established blood supply network and distribution capability that ensures timely availability of required blood types and components (e.g., red blood cells, plasma, platelets). The vendor s proximity and existing logistical infrastructure allow for rapid fulfillment of routine and urgent transfusion needs, which is critical to avoid delays in patient treatment. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of the agency. The determination not to compete this proposed action is solely within the discretion of the Government. Information received normally will be considered for the purpose of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred for responding to this notice. This is not a solicitation nor a request for quote. Questions or comments to this Notice of Intent should be directed to Purchasing Agent, Teri Kittson by email at teri.kittson@ihs.gov Please include the following wording in the subject line of the email: Notice of Intent Questions Submission BFSU Blood and Blood Products Services. Telephone requests and offers will not be honored.
From Special Notice posted on Mar 16, 2026Notice history
1Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA